Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension

[1]  K. Schmidt,et al.  Kinetics of 111In-labelled platelets in healthy subjects. , 2009, Scandinavian journal of haematology.

[2]  P. E. Madsen,et al.  Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia. , 2009, Scandinavian journal of haematology.

[3]  J. Bussel,et al.  Long term follow‐up after splenectomy performed for immune thrombocytopenic purpura (ITP) , 2003, American journal of hematology.

[4]  N. Soper,et al.  Portal vein thrombosis after splenectomy. , 2002, American journal of surgery.

[5]  D. Wyss,et al.  Structure, biology, and therapeutic implications of pegylated interferon alpha-2b. , 2002, Current pharmaceutical design.

[6]  William M. Lee,et al.  Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. , 2002, Gastroenterology.

[7]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[8]  M. Hashizume,et al.  Laparoscopic splenectomy for portal hypertension. , 2002, Hepato-gastroenterology.

[9]  B. Heniford,et al.  Laparoscopic splenectomy for massive splenomegaly. , 2002, American journal of surgery.

[10]  M. Hashizume,et al.  Effects of splenectomy on liver volume and prognosis of cirrhosis in patients with esophageal varices 1 , 2002, Journal of gastroenterology and hepatology.

[11]  B. Heniford,et al.  Laparoscopic Splenectomy for Malignant Diseases , 2000, Seminars in laparoscopic surgery.

[12]  A. Johnson,et al.  Mismatch between trainees' subspecialist interest and advertised jobs; worrying implications for upper gastrointestinal trainees , 2000, The British journal of surgery.

[13]  R. Saad,et al.  Portal vein thrombosis following splenectomy , 2000, The British journal of surgery.

[14]  William M. Lee,et al.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.

[15]  W. Irish,et al.  Does Transjugular Intrahepatic Portosystemic Shunt (TIPS) Resolve Thrombocytopenia Associated with Cirrhosis? , 1998, Digestive Diseases and Sciences.

[16]  C. Datz,et al.  Blunted thrombopoietin response to interferon alfa–induced thrombocytopenia during treatment for hepatitis C , 1998, Hepatology.

[17]  M. Shuman,et al.  Interferon‐induced thrombocytopenia: Is it time for thrombopoietin? , 1998, Hepatology.

[18]  P. Marcellin,et al.  Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus , 1998, The Lancet.

[19]  P. Chaffanjon,et al.  Portal Vein Thrombosis following Splenectomy for Hematologic Disease: Prospective Study with Doppler Color Flow Imaging , 1998, World Journal of Surgery.

[20]  S. Stitham.  A piece of my mind. Educational malpractice. , 1991, JAMA.

[21]  J. Hoofnagle.  Thrombocytopenia during interferon alfa therapy. , 1991, JAMA.

[22]  J. Hoofnagle,et al.  Side Effects of Alpha Interferon , 1989, Seminars in liver disease.

[23]  M. Kutner,et al.  Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. , 1985, Surgery, gynecology & obstetrics.

[24]  N. Soper,et al.  Effect of operations for variceal hemorrhage on hypersplenism. , 1982, American journal of surgery.

[25]  E. Lerner,et al.  Effect of portacaval anastomosis on hypersplenism , 1980, Digestive Diseases and Sciences.

[26]  N. Mantel,et al.  The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. , 1962, The New England journal of medicine.

[27]  Kenneth Koury,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .